Insmed Incorporated
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
INSM News
US-based Insmed has shared more data from the Phase III ASPEN trial, showing that brensocatib also reduced the decline in lung function in bronchiectasis patien...
Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a lot more than 100%. For example, the Insmed...
Insmed (INSM) has issued an update. Insmed Incorporated has announced new results from its ASPEN study, which evaluates the effectiveness and safety of the dru...
Analyst ratings
100%
of 17 ratingsMore INSM News
The field of bronchiectasis had been previously unexplored, but recent studies have shed light on the mechanisms behind the disease pathophysiology. This has le...
Bearish flow noted in Insmed with 4,202 puts trading, or 1.7x expected. Most active are Dec-24 20 puts and Jul-24 75 calls, with total volume in those strikes n...